These results have strengthened the evidence of SPHK1 as a newfound player in the development and survival of erythroleukemic cells and may provide a foundation for future therapeutic exploration of SPHK1 in acute erythroleukemia. This evidence concerns the gene SPHK1 and erythroleukemia.